NAGA antibody (AA 312-411)

Catalog No. ABIN6144342

Product Details anti-NAGA Antibody

Target: NAGA (N-Acetylgalactosaminidase, alpha (NAGA))

Binding Specificity: AA 312-411

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This NAGA antibody is un-conjugated

Application: Western Blotting (WB), Immunofluorescence (IF)

Sequence: IQGRRIHKEK SLIEVYMRPL SNKASALVFF SCRTDMPYRY HSSLGQLNFT GSVIYEAQDV YSGDIISGLR DETNFTVIIN PSGVVMWYLY PIKNLEMSQQ

Cross-Reactivity: Human, Mouse, Rat

Characteristics: Polyclonal Antibodies

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 312-411 of human NAGA (NP_000253.1).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000,IF,1:50 - 1:200

Comment:

HIGH QUALITY

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for NAGA

Target: NAGA (N-Acetylgalactosaminidase, alpha (NAGA))

Alternative Name: NAGA (NAGA Products)

Synonyms: D22S674 antibody, GALB antibody, alpha-N-acetylgalactosaminidase antibody, N-acetyl galactosaminidase, alpha antibody, Naga antibody, NAGA antibody

Background: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).,NAGA,D22S674,GALB,Cancer,Signal Transduction,Endocrine & Metabolism,NAGA

Molecular Weight: 46 kDa

Gene ID: 4668

UniProt: P17050